⌘K
Loading ticker…
As of 2026-08-24, Mesa Laboratories Inc (MLAB) has a 3-month relative strength percentile of 74 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.5%, relative volume 0.94×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
MLAB is in a stage 2 uptrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 21.8% / 34.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
MLAB appears in 1 ETF as of Jun 2026: PSC at 0.05% weight, $1M notional.
Held by 45 ETFs · $61M across latest filings · largest weight 1.67% (KDVD).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.05% | $1M | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MLAB Jan avg: 2.31% median: 2.37% win: 75% σ: 12.20% n: 4 2022-04-12 → 2026-07-31 | MLAB Feb avg: 8.44% median: 10.20% win: 75% σ: 15.07% n: 4 2022-04-12 → 2026-07-31 | MLAB Mar avg: -5.96% median: -4.73% win: 25% σ: 7.11% n: 4 2022-04-12 → 2026-07-31 | MLAB Apr avg: -2.18% median: -3.33% win: 20% σ: 9.50% n: 5 2022-04-12 → 2026-07-31 | MLAB May avg: -8.95% median: -9.79% win: 20% σ: 9.47% n: 5 2022-04-12 → 2026-07-31 | MLAB Jun avg: -4.28% median: -2.54% win: 0% σ: 3.49% n: 5 2022-04-12 → 2026-07-31 | MLAB Jul avg: 3.82% median: 1.27% win: 80% σ: 18.21% n: 5 2022-04-12 → 2026-07-31 | MLAB Aug avg: -0.78% median: 0.01% win: 50% σ: 17.64% n: 4 2022-04-12 → 2026-07-31 (current) | MLAB Sep avg: -12.06% median: -10.22% win: 0% σ: 12.25% n: 4 2022-04-12 → 2026-07-31 | MLAB Oct avg: -5.43% median: -8.41% win: 25% σ: 8.86% n: 4 2022-04-12 → 2026-07-31 | MLAB Nov avg: 8.30% median: 7.14% win: 75% σ: 15.58% n: 4 2022-04-12 → 2026-07-31 | MLAB Dec avg: 7.86% median: 5.41% win: 50% σ: 12.04% n: 4 2022-04-12 → 2026-07-31 |